These findings strongly suggest that LCZ suppresses TPA‐induced irritant dermatitis by inhibiting the production of neutrophil chemotactic factors such as KC or MIP‐2 and the subsequent infiltration of activated neutrophils into the skin. The gene discussed is CXCL2; the disease is irritant dermatitis.